시장보고서
상품코드
1130892

RNA 시퀀싱 서비스 시장 : 시퀀싱 방법별, 응용 분야별, 최종사용자 업계별, 주요 지역별 - 업계 동향과 세계 예측(2022-2035년)

RNA Sequencing Services Market: Distribution by Type of Sequencing Method, Application Area, End User Industry and Key Geographical Regions : Industry Trends and Global Forecasts, 2022-2035

발행일: | 리서치사: Roots Analysis | 페이지 정보: 영문 159 Pages | 배송안내 : 1-2일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 RNA 시퀀싱 서비스(RNA Sequencing Services) 시장에 대해 조사했으며, 시장 개요, 시퀀싱 방법별/응용 분야별/최종사용자 업계별/주요 지역별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

제2장 개요

제3장 서론

제4장 RNA 시퀀싱 서비스 프로바이더 : 시장 개요

  • 본 장의 개요

제5장 기업의 경쟁력 분석

  • 본 장의 개요
  • 가정과 주요 파라미터
  • 범위와 조사 방법
  • 기업 경쟁력 분석 : 북미의 RNA 시퀀싱 서비스 프로바이더
  • 기업 경쟁력 분석 : 유럽의 RNA 시퀀싱 서비스 프로바이더
  • 기업 경쟁력 분석 : 아시아태평양 및 기타 지역의 RNA 시퀀싱 서비스 프로바이더

제6장 기업 개요

  • 본 장의 개요
  • Admera Health
  • Biogazelle(acquired by CellCarta)
  • CD Genomics
  • Creative Biogene
  • IGA Technology
  • LC Sciences
  • Lexogen
  • Novogene
  • Otogenetics
  • Yaazh Xenomic

제7장 학술 보조금 분석

  • 본 장의 개요
  • 범위와 조사 방법
  • 조성년도별 분석

제8장 특허 분석

  • 본 장의 개요
  • 범위와 조사 방법
  • RNA 시퀀싱 : 특허 분석
  • RNA 시퀀싱 : 특허 벤치마킹 분석
  • RNA 시퀀싱 : 특허 평가 분석
  • 주요 특허 : 인용 횟수별 분석

제9장 Porter의 산업 분석

제10장 사례 연구 : NGS 라이브러리 조제 키트

  • 본 장의 개요
  • NGS 라이브러리 조제 키트 : 전체적인 시장 구도
  • NGS 라이브러리 준비 키트 : 개발업체 상황

제11장 투자 가능성 분석

제12장 시장 규모와 기회 분석

  • 본 장의 개요
  • 예측 조사 방법과 주요 가정
  • 세계의 RNA 시퀀싱 서비스 시장, 2022-2035년

제13장 주요 인사이트

제14장 부록 1 : 표 형식 데이터

제15장 부록 2 : 기업 및 조직 리스트

LSH 22.10.13

INTRODUCTION

RNA sequencing was first introduced by Fredrick Sanger in 1977, who used chain termination method, also known sanger sequencing method / first generation sequencing method. It is a rapid method that enables profiling of whole range of RNA expressed by the cell, with increased coverage and resolution. However, the sanger sequencing method costs higher as compared to other methods and has low detection power, which reduces its scalability. Over time, this domain has witnessed several technological advancements, and different methods of RNA sequencing are now being used for differential gene and allele-specific expression, small RNA profiling, and characterization of alternative splicing patterns and system biology. Among various sequencing methods, next generation sequencing (NGS) introduced by Lynx Therapeutics in 2000, has emerged as a preferred choice across the industry. It is a high throughput, parallel genome sequencing technology, which enables whole genome and whole exome sequencing. It enables reduction in overall cost and process time. Despite the various technological advancements in RNA sequencing, there are several existing challenges, including difficulty in sequencing of large genes, shortage of human resources and lack of tools for data manipulation and analysis. In addition, establishment and maintenance of next generation sequencing based facilities require high capital. In order to overcome these challenges and obtain a high-quality output, the outsourcing of RNA sequencing is considered as a preferable option, among other alternatives, by industry players.

Currently, more than 70 companies offer services related to RNA sequencing. A number of these companies are start-ups that have been established in the past decade. In addition, several stakeholders are engaged in the development of proprietary technologies in order to overcome the errors related to amplification and duplication rates while sequencing. Further, over 340 patents related to RNA sequencing have been recently filed / granted, which demonstrates the innovation and continuous research efforts in this domain. Moreover, over the last few years, grants worth USD 486 million have been awarded by National Institutes of Health to support the ongoing R&D efforts in this domain. Driven by the growing interest of various stakeholders and the wide applicability of this technique, we believe that the RNA sequencing services industry is anticipated to witness noteworthy growth in the foreseen future.

SCOPE OF THE REPORT

The 'RNA Sequencing Services Market, 2022-2035: Distribution by Type of Sequencing Method (Next Generation Sequencing Method, and Other Methods), Application Area (Diagnostic and Research), End User Industry (Academic and Research, Clinics and Hospital, Pharmaceutical Industry and Others), Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, 2022-2035' report features an extensive study of the current market landscape and future potential of the RNA sequencing services market. The study also includes an in-depth analysis, highlighting the capabilities of RNA sequencing service providers. Amongst other elements, the report features:

  • A general overview of RNA sequencing, along with information on the key steps involved in the process, details on the various types, methods and applications of RNA sequencing, as well as the advantages and limitations associated with RNA sequencing. It further includes details on the different types of RNA sequencing platforms.
  • A detailed overview of the market landscape of RNA sequencing service providers, based on several relevant parameters, such as their year of establishment, company size (in terms of number of employees), region of headquarters (North America, Europe, Asia-Pacific and MENA). In addition, the chapter features information on the various offerings of such service providers, including type of RNA sequencing service(s), type of platform (Illumina, PacBio, Nanopore and others), turnaround time, type of sample (human, animal, plant, microorganisms and others) and volume of sample.
  • A competitiveness analysis of RNA sequencing service providers, located in North America, Europe, and Asia Pacific and Rest of the World. The analysis compares service providers on the basis of various relevant parameters, such as experience of the company (in terms of number of years since it was established), service portfolio strength (in terms of number of RNA sequencing services offered, number of samples and turnaround time) and platform diversity (in terms of number of RNA sequencing services offered via respective sequencing platforms).
  • Elaborate profiles of key players involved in providing services for RNA sequencing. Each profile features a brief overview of the company, details on its service portfolio and recent developments, along with an informed future outlook.
  • An in-depth analysis of grants awarded to various research institutes for projects related to RNA sequencing, since 2018, based on several relevant parameters, such as year of grant awarded, amount awarded, administering institute center, support period, type of grant application, purpose of grant, activity code, study section, type of organization, emerging focus areas, popular NIH departments, popular recipient organizations (in terms of number of grants and amount awarded), prominent program officers and location of recipient organizations.
  • An insightful analysis of patents filed / granted for RNA sequencing, since 2018, taking into consideration various relevant parameters, such as type of patent, publication year, application year, geographical location, CPC symbols, emerging focus areas, type of applicant, leading players and individual assignees (in terms of number of patents granted / filed in the given time period). In addition, the chapter includes a detailed patent benchmarking and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
  • A qualitative analysis of the five competitive forces, including threats of new entrants, bargaining power of customers, bargaining power of RNA sequencing service providers, threats of substitute services and rivalry among existing competitors under an insightful Porter's Five Forces framework.
  • A case study on NGS library preparation kits, based on type of platform, amount of sample, turnaround time, storage temperature, type of sequencing(s), kit components, type of sample. In addition, it includes a study on NGS library preparation kit developers, featuring analyses based on their year of establishment, company size and geographical presence.
  • An insightful analysis, highlighting financial attributes (payback period, total cash inflow, and earning potential of platforms) that need to be taken into consideration by various RNA sequencing service providers to facilitate decision making to employ sequencing platform.

One of the key objectives of the report was to estimate the current market size and the future potential associated with the RNA sequencing services market, over the coming 13 years. We have provided informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of sequencing method (next generation sequencing method and other methods), application area (diagnostic and research), end user industry (academic and research, clinics and hospital, pharmaceutical industry, and others), and key geographical regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the market's evolution.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews with experts in the area (academia, industry and other associations) to solicit their opinions on emerging trends in the market. The information is primarily useful for us to draw out our opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been validated from multiple sources of information.

The secondary sources of information include:

  • Annual reports
  • Investor presentations
  • SEC filings
  • Industry databases
  • News releases from company websites
  • Government policy documents
  • Industry analysts' views

While the focus has been on forecasting the market till 2035, the report also provides our independent views on various non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

  • Who are the key players engaged in offering RNA sequencing services?
  • What is the average turnaround time of RNA sequencing services currently offered?
  • What is the relative competitiveness of different RNA sequencing service providers?
  • How has the intellectual property landscape of RNA sequencing evolved over the years?
  • Which are the leading funding institutes / centers supporting research related to RNA sequencing?
  • Which type of next generation sequencing kits are being used to collect samples for RNA sequencing?
  • Which sequencing platform is likely to offer highest earning potential to service providers?
  • How is the current and future market opportunity likely to be distributed across key market segments?

CHAPTER OUTLINES

Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of the RNA sequencing services market and its likely evolution in the short-mid to long term.

Chapter 3 provides a general overview of RNA sequencing, along with information on the key steps involved in the process, details on the various types, methods and applications of RNA sequencing, the advantages and limitations associated with RNA sequencing. It also includes details of the different RNA sequencing platforms.

Chapter 4 presents a detailed overview of the overall market landscape of RNA sequencing service providers, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), region of headquarters (North America, Europe, Asia-Pacific and MENA). In addition to this, the chapter also features information on type of RNA sequencing service(s), type of platform (Illumina, PacBio, Nanopore and others), turnaround time, type of sample (human, animal, plant, microorganisms and others) and volume of sample.

Chapter 5 provides a competitiveness analysis of RNA sequencing service providers, located in North America, Europe, and Asia Pacific and Rest of the World. The analysis compares the service providers on the basis of various relevant parameters, such as overall experience of the company (in terms of number of years since it was established), service portfolio strength (in terms of number of RNA sequencing services offered, number of samples and turnaround time) and platform diversity (in terms of number of RNA sequencing services offered via respective sequencing platforms).

Chapter 6 elaborate profiles of the prominent players involved in providing services for RNA sequencing. Each profile features a brief overview of the company, details on its service portfolio and recent developments with an informed future outlook.

Chapter 7 provides an in-depth analysis of grants awarded to various research institutes for the projects related to RNA sequencing, since 2018, based on several relevant parameters, such as year of grant awarded, amount awarded, administering institute center, support period, type of grant application, purpose of grant, activity code, study section, type of organization, emerging focus areas, popular NIH departments, popular recipient organizations (in terms of number of grants and amount awarded), prominent program officers and location of recipient organizations.

Chapter 8 features an insightful analysis of the patents filed / granted for RNA sequencing, since 2018, taking into consideration various relevant parameters, such as type of patent, publication year, application year, geographical location, CPC symbols, emerging focus areas, type of applicant, leading players and individual assignees (in terms of number of patents granted / filed in the given time period). In addition, the chapter includes a detailed patent benchmarking and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).

Chapter 9 provides a qualitative analysis of the five competitive forces, including threats of new entrants, bargaining power of customers, bargaining power of RNA sequencing service providers, threats of substitute services and rivalry among existing competitors under an insightful Porter's Five Forces framework.

Chapter 10 presents a case study on NGS library preparation kits, based on a type of platform, amount of sample, turnaround time, storage temperature, type of sequencing(s), kit components, type of sample. In addition, it includes a study on NGS library preparation kit developers, featuring analyses based on their year of establishment, company size, and geographical presence.

Chapter 11 presents an insightful analysis, highlighting financial attributes (payback period, total cash inflow, and earning potential of platforms) that need to be taken into consideration by various RNA sequencing service providers to facilitate decision making to employ sequencing platform.

Chapter 12 features a detailed market forecast of the likely growth of RNA sequencing, till the year 2035. It also includes insights on the likely distribution of the current and forecasted opportunity across the type of sequencing method (next generation sequencing method and other methods), application area (diagnostic and research), end user industry (academic and research, clinics and hospital, pharmaceutical industry, and others), and key geographical regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa).

Chapter 13 provides the transcripts of the interviews conducted with senior representatives of renowned organizations that are engaged in the RNA sequencing.

Chapter 14 is an appendix, that contains tabulated data and numbers for all the figures provided in the report.

Chapter 15 is an appendix, that contains the list of companies and organizations mentioned in the report.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4 Key Questions Answered
  • 1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. An Overview of RNA Sequencing
    • 3.2.1. Key Steps Involved in RNA Sequencing
    • 3.2.2. Types of RNA Sequencing
      • 3.2.2.1. Single End Sequencing
      • 3.2.2.2. Paired End Sequencing
    • 3.2.3. Methods of RNA Sequencing
      • 3.2.3.1. First Generation Sequencing
      • 3.2.3.2. Next Generation Sequencing
      • 3.2.3.3. Third Generation Sequencing
    • 3.2.4. Applications of RNA Sequencing
    • 3.2.5. Advantages of RNA Sequencing
    • 3.2.6. Limitations of RNA Sequencing
    • 3.2.7. RNA Sequencing Platforms
      • 3.2.7.1. Illumina Sequencing Platforms
      • 3.2.7.2. Pac Bio Sequencing Platforms
      • 3.2.7.3. Nanopore Sequencing Platforms
  • 3.3. Concluding Remarks

4. RNA SEQUENCING SERVICE PROVIDERS: MARKET OVERVIEW

  • 4.1. Chapter Overview
    • 4.1.1. RNA Sequencing Service Providers
    • 4.1.2. Analysis by Year of Establishment
    • 4.1.3. Analysis by Company Size
    • 4.1.4. Analysis by Location of Headquarters
    • 4.1.5. Analysis by Company Size and Region of Headquarters
    • 4.1.6. Analysis by Type of RNA Sequencing Service(s)
    • 4.1.7. Analysis by Type of Platform
    • 4.1.8. Analysis by Turnaround Time
    • 4.1.9. Analysis by Type of Sample
    • 4.1.10. Analysis by Amount of Sample

5. COMPANY COMPETITIVENESS ANALYSIS

  • 5.1. Chapter Overview
  • 5.2. Assumptions and Key Parameters
  • 5.3. Scope and Methodology
  • 5.4. Company Competitiveness Analysis: RNA Sequencing Service Providers in North America
  • 5.5. Company Competitiveness Analysis: RNA Sequencing Service Providers in Europe
  • 5.6. Company Competitiveness Analysis: RNA Sequencing Service Providers in Asia-Pacific and Rest of the World

6. COMPANY PROFILES

  • 6.1. Chapter Overview
  • 6.2. Admera Health
    • 6.2.1. Company Overview
    • 6.2.2. RNA Sequencing Service Portfolio
    • 6.2.3. Recent Developments and Future Outlook
  • 6.3. Biogazelle (acquired by CellCarta)
    • 6.3.1. Company Overview
    • 6.3.2. RNA Sequencing Service Portfolio
    • 6.3.3. Recent Developments and Future Outlook
  • 6.4. CD Genomics
    • 6.4.1. Company Overview
    • 6.4.2. RNA Sequencing Service Portfolio
    • 6.4.3. Recent Developments and Future Outlook
  • 6.5. Creative Biogene
    • 6.5.1. Company Overview
    • 6.5.2. RNA Sequencing Service Portfolio
    • 6.5.3. Recent Developments and Future Outlook
  • 6.6. IGA Technology
    • 6.6.1. Company Overview
    • 6.6.2. RNA Sequencing Service Portfolio
    • 6.6.3. Recent Developments and Future Outlook
  • 6.7. LC Sciences
    • 6.7.1. Company Overview
    • 6.7.2. RNA Sequencing Service Portfolio
    • 6.7.3. Recent Developments and Future Outlook
  • 6.8. Lexogen
    • 6.8.1. Company Overview
    • 6.8.2. RNA Sequencing Service Portfolio
    • 6.8.3. Recent Developments and Future Outlook
  • 6.9. Novogene
    • 6.9.1. Company Overview
    • 6.9.2. RNA Sequencing Service Portfolio
    • 6.9.3. Recent Developments and Future Outlook
  • 6.10. Otogenetics
    • 6.10.1. Company Overview
    • 6.10.2. RNA Sequencing Service Portfolio
    • 6.10.3. Recent Developments and Future Outlook
  • 6.11. Yaazh Xenomic
    • 6.11.1. Company Overview
    • 6.11.2. RNA Sequencing Service Portfolio
    • 6.11.3. Recent Developments and Future Outlook

7. ACADEMIC GRANT ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Scope and Methodology
  • 7.3. Analysis by Year of Grant Award
    • 7.3.1. Analysis by Amount Awarded
    • 7.3.2. Analysis by Administering Institute Centre
    • 7.3.3. Analysis by Support Period
    • 7.3.4. Analysis by Administering Institute Centre and Support Period
    • 7.3.5. Analysis by Type of Grant Application
    • 7.3.6. Analysis by Purpose of Grant
    • 7.3.7. Analysis by Purpose of Grant and Amount Awarded
    • 7.3.8. Analysis by Activity Code
    • 7.3.9. Analysis by Study Section Involved
    • 7.3.10. Analysis by Type of Organization
    • 7.3.11. Word Cloud: Emerging Focus Areas
    • 7.3.12. Most Popular Departments: Analysis by Number of Grants
    • 7.3.13. Prominent Program Officers: Analysis by Number of Grants
    • 7.3.14. Popular Recipient Organizations: Analysis by Number of Grants
    • 7.3.15. Popular Recipient Organizations: Analysis by Amount Awarded
    • 7.3.16. Analysis of Recipient Organizations located in the US

8. PATENT ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Scope and Methodology
  • 8.3. RNA Sequencing: Patent Analysis
    • 8.3.1. Analysis by Publication Year
    • 8.3.2. Analysis by Application Year
    • 8.3.3. Analysis by Annual Number of Granted Patents and Patent Applications
    • 8.3.4. Analysis by Geography
    • 8.3.5. Analysis by CPC Symbols
    • 8.3.6. Analysis by Focus Area
    • 8.3.7. Analysis by Type of Applicant
    • 8.3.8. Leading Players: Analysis by Number of Patents
    • 8.3.9. Leading Individual Assignees: Analysis by Number of Patents
  • 8.4. RNA Sequencing: Patent Benchmarking Analysis
    • 8.4.1. Analysis by Patent Characteristics
  • 8.5. RNA sequencing: Patent Valuation Analysis
  • 8.6. Leading Patents: Analysis by Number of Citations

9. PORTER'S FIVE FORCES ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Methodology and Assumptions
  • 9.3. Key Parameters
    • 9.3.1. Threats of New Entrants
    • 9.3.2. Bargaining Power of Customers
    • 9.3.3. Bargaining Power of RNA Sequencing Service Providers
    • 9.3.4. Threats of Substitute Services
    • 9.3.5. Rivalry Among Existing Competitors
  • 9.4. Concluding Remarks

10. CASE STUDY: NGS LIBRARY PREPARATION KITS

  • 10.1. Chapter Overview
  • 10.2. NGS Library Preparation Kits: Overall Market Landscape
    • 10.2.1. Analysis by Type of Platform
    • 10.2.2. Analysis by Amount of Sample
    • 10.2.3. Analysis by Turnaround Time
    • 10.2.4. Analysis by Storage Temperature
    • 10.2.5. Analysis by Type of Sequencing
    • 10.2.6. Analysis by Kit Components
    • 10.2.7. Analysis by Type of Sample
  • 10.3. NGS Library Preparation Kits: Developer Landscape
    • 10.3.1. Analysis by Year of Establishment
    • 10.3.2. Analysis by Company Size
    • 10.3.3. Analysis by Region of Headquarters

11. INVESTMENT POTENTIAL ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Profit Potential of Commonly used RNA Sequencing Platforms
    • 11.2.1. iSeq: Likely Profit Potential
    • 11.2.2. MiSeq: Likely Profit Potential
    • 11.2.3. NextSeq 550 Series: Likely Profit Potential
    • 11.2.4. NextSeq 1000 & 2000: Likely Profit Potential
    • 11.2.5. NextSeq 1000 & 2000: Likely Profit Potential
    • 11.2.6. Sequel: Likely Profit Potential
    • 11.2.7. Sequel II: Likely Profit Potential
    • 11.2.8. Sequel IIe: Likely Profit Potential
  • 11.4. Payback Evaluation Matrix
  • 11.3. Conclusion

12. MARKET SIZING AND OPPORTUNITY ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Forecast Methodology and Key Assumptions
  • 12.3. Global RNA Sequencing Services Market, 2022-2035
    • 12.3.1. RNA Sequencing Services Market, 2022-2035: Distribution by Type of Sequencing Method
      • 12.3.1.1. RNA Sequencing Services Market for Next Generation Sequencing Methods, 2022-2035
      • 12.3.1.2. RNA Sequencing Services Market for Other Methods, 2022-2035
    • 12.3.2. RNA Sequencing Services Market, 2022-2035: Distribution by Type of Application
      • 12.3.2.1. RNA Sequencing Services Market for Research Purposes, 2022-2035
      • 12.3.2.2. RNA Sequencing Services Market for Diagnostic Purposes, 2022-2035
    • 12.3.3. RNA Sequencing Services Market, 2022-2035: Distribution by Type of End User
      • 12.3.3.1. RNA Sequencing Services Market for Academic and Research Industry, 2022-2035
      • 12.3.3.2. RNA Sequencing Services Market for Clinics and Hospitals, 2022-2035
      • 12.3.3.3. RNA Sequencing Services Market for Pharmaceutical Industry, 2022-2035
      • 12.3.3.4. RNA Sequencing Services Market for Other Users, 2022-2035
    • 12.3.4. RNA Sequencing Services Market, 2022-2035: Distribution by Key Geographical Regions
      • 12.3.4.1. RNA Sequencing Services Market in North America, 2022-2035
      • 12.3.4.2. RNA Sequencing Services Market in Europe, 2022-2035
      • 12.3.4.3. RNA Sequencing Services Market in Asia-Pacific, 2022-2035
      • 12.3.4.4. RNA Sequencing Services Market in Latin America, 2022-2035
      • 12.3.4.5. RNA Sequencing Services Market in Middle East and North Africa, 2022-2035

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제